Kazia Therapeutics (KZIA) Receivables - Other (2018 - 2025)
Kazia Therapeutics (KZIA) has disclosed Receivables - Other for 2 consecutive years, with $27402.8 as the latest value for Q2 2023.
- For the quarter ending Q2 2023, Receivables - Other fell 4.36% year-over-year to $27402.8, compared with a TTM value of $27402.8 through Jun 2023, down 4.36%, and an annual FY2023 reading of $27610.1, down 4.92% over the prior year.
- Receivables - Other was $27402.8 for Q2 2023 at Kazia Therapeutics, down from $28650.7 in the prior quarter.
- Across five years, Receivables - Other topped out at $28650.7 in Q2 2022 and bottomed at $27402.8 in Q2 2023.